Prosecution Insights
Last updated: October 02, 2026

Examiner: BLASS, PARIS MARIE

Tech Center 3700 • Art Units: 2844 3774

This examiner grants 54% of resolved cases

Analysis

Paris Marie Blass is an examiner in Tech Center 3700, working in Art Unit 2844. She has 33 resolved cases, which is a smaller sample size but still provides insights into her early examination trends. Her work in these units involves mechanical and electrical technologies. The 33 resolved cases serve as the current basis for evaluating her performance metrics.

The allowance rate for this examiner is 54.5 percent. This indicates a moderate level of success for applicants, with more than half of the cases resulting in a grant. The median days to allowance is 1320, which suggests a longer prosecution cycle. Applicants should be prepared for a process that may take several years to reach a final resolution, as indicated by the 1320 median days to allowance and the 54.5 percent allowance rate.

The interview lift is 39.6 percent. This is a high lift, indicating that interviews are an effective tool for this examiner compared to the baseline allowance rate of 54.5 percent. The data suggests that direct communication can significantly improve the chances of overcoming rejections. Given the 54.5 percent allowance rate and the 1320 median days to allowance, practitioners should prioritize scheduling interviews to address the examiner's concerns. This proactive approach appears to be one of the best ways to navigate her docket successfully, as shown by the 39.6 percent lift.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.5%
Allow Rate
-15.5% vs TC avg
77
Total Applications
+39.6%
Interview Lift
1320
Avg Prosecution Days
Based on 33 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
30.7%
§102 Novelty
53.1%
§103 Obviousness
15.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18233067 STENT DEVICE FOR SPINAL FUSION Non-Final OA MiRus LLC
18703819 CONVERTIBLE GLENOID IMPLANTS Non-Final OA HOWMEDICA OSTEONICS CORP.
18311458 Automated Balloon Inflation Device for Transcatheter Heart Valve Implantation Non-Final OA St. Jude Medical, Cardiology Division, Inc.
17688152 Expandable Stent For A Transcatheter Prosthetic Heart Valve Final Rejection St. Jude Medical, Cardiology Division, Inc.
18048580 SURGICAL IMPLANT DELIVERY WITH DAMPING Final Rejection Alcon Inc.
18828165 COLLAPSIBLE COIL ANTENNA Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18589031 LEAFLET SUPPORT DEVICES AND METHODS OF MAKING AND USING THE SAME Non-Final OA EDWARDS LIFESCIENCES CORPORATION
17681660 SYSTEMS AND METHODS FOR TRICUSPID VALVE TREATMENT Final Rejection Edwards Lifesciences Corporation
17602222 PATENT DUCTUS ARTERIOSUS STENT Final Rejection Vanderbilt University
18057399 Delivery Catheter System With Micro and Macro Movement Control Non-Final OA Medtronic, Inc.
18303291 AUGMENTATION DEVICE AND METHOD FOR ADAPTING AN AUGMENTATION DEVICE Non-Final OA Heraeus Medical GmbH
17913253 INTRAOCULAR LENS REPOSITIONING DEVICE Non-Final OA University of South Florida
18006154 COATING OF A STRUCTURED IMPLANT SURFACE Final Rejection WALDEMAR LINK GmbH & Co. KG
17712290 Frame Features for Transcatheter Mitral Valve Replacement Device Non-Final OA Cephea Valve Technologies, Inc.
18340142 DMEK ENDOTHELIUM-IN DELIVERY DEVICE Final Rejection Lions World Vision Institute, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month